478 related articles for article (PubMed ID: 28456365)
1. Medication management after intramedullary nailing of atypical fractures.
Feron JM; Cambon-Binder A
Injury; 2017 Jun; 48 Suppl 1():S15-S17. PubMed ID: 28456365
[TBL] [Abstract][Full Text] [Related]
2. Atypical diaphyseal femoral fractures: Considerations on surgical technique.
Spinelli MS; Marini E; Daolio PA; Piccioli A
Injury; 2019 Jul; 50 Suppl 2():S65-S69. PubMed ID: 30782394
[TBL] [Abstract][Full Text] [Related]
3. Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide.
Miyakoshi N; Aizawa T; Sasaki S; Ando S; Maekawa S; Aonuma H; Tsuchie H; Sasaki H; Kasukawa Y; Shimada Y
J Bone Miner Metab; 2015 Sep; 33(5):553-9. PubMed ID: 25227287
[TBL] [Abstract][Full Text] [Related]
4. Different surgical outcomes in a patient with bilateral atypical femoral fracture related to bisphosphonate use with or without teriparatide treatment.
Zhang HY; Weng HL; Li M; Zhang J
Osteoporos Int; 2019 Nov; 30(11):2349-2354. PubMed ID: 31428823
[TBL] [Abstract][Full Text] [Related]
5. Use of teriparatide in osteoporotic fracture patients.
Collinge C; Favela J
Injury; 2016 Jan; 47 Suppl 1():S36-8. PubMed ID: 26768289
[TBL] [Abstract][Full Text] [Related]
6. Incidence, risk factors, and fracture healing of atypical femoral fractures: a multicenter case-control study.
Lim SJ; Yeo I; Yoon PW; Yoo JJ; Rhyu KH; Han SB; Lee WS; Song JH; Min BW; Park YS
Osteoporos Int; 2018 Nov; 29(11):2427-2435. PubMed ID: 30039251
[TBL] [Abstract][Full Text] [Related]
7. Factors Associated with Increased Healing Time in Complete Femoral Fractures After Long-Term Bisphosphonate Therapy.
Lim HS; Kim CK; Park YS; Moon YW; Lim SJ; Kim SM
J Bone Joint Surg Am; 2016 Dec; 98(23):1978-1987. PubMed ID: 27926679
[TBL] [Abstract][Full Text] [Related]
8. Current Understanding of Epidemiology, Pathophysiology, and Management of Atypical Femur Fractures.
Starr J; Tay YKD; Shane E
Curr Osteoporos Rep; 2018 Aug; 16(4):519-529. PubMed ID: 29951870
[TBL] [Abstract][Full Text] [Related]
9. The effects of teriparatide on acceleration of bone healing following atypical femoral fracture: comparison between daily and weekly administration.
Tsuchie H; Miyakoshi N; Iba K; Kasukawa Y; Nozaka K; Dohke T; Kosukegawa I; Aizawa T; Maekawa S; Abe H; Takeshima M; Tomite T; Segawa T; Ouchi K; Kinoshita H; Suzuki M; Yamashita T; Shimada Y
Osteoporos Int; 2018 Dec; 29(12):2659-2665. PubMed ID: 30105400
[TBL] [Abstract][Full Text] [Related]
10. Healing delayed but generally reliable after bisphosphonate-associated complete femur fractures treated with IM nails.
Egol KA; Park JH; Rosenberg ZS; Peck V; Tejwani NC
Clin Orthop Relat Res; 2014 Sep; 472(9):2728-34. PubMed ID: 23604648
[TBL] [Abstract][Full Text] [Related]
11. Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series.
Bögl HP; Aspenberg P; Schilcher J
Osteoporos Int; 2017 Aug; 28(8):2439-2444. PubMed ID: 28474166
[TBL] [Abstract][Full Text] [Related]
12. Atypical femur fractures.
Borrelli J; Lane J; Bukata S; Egol KA; Takemoto R; Slobogean G; Morshed S
J Orthop Trauma; 2014; 28 Suppl 1():S36-42. PubMed ID: 24476604
[TBL] [Abstract][Full Text] [Related]
13. Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment.
Yeh WL; Su CY; Chang CW; Chen CH; Fu TS; Chen LH; Lin TY
BMC Musculoskelet Disord; 2017 Dec; 18(1):527. PubMed ID: 29237448
[TBL] [Abstract][Full Text] [Related]
14. The effect of teriparatide on patients with atypical femur fractures: a systematic review and meta-analysis.
Salamah HM; Abualkhair KA; Kamal SK; Mohamed HA; Alkheder A; Farho MA; Mistry D; Elbardesy H
Arch Orthop Trauma Surg; 2024 Mar; 144(3):1091-1106. PubMed ID: 38135789
[TBL] [Abstract][Full Text] [Related]
15. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.
Shane E; Burr D; Abrahamsen B; Adler RA; Brown TD; Cheung AM; Cosman F; Curtis JR; Dell R; Dempster DW; Ebeling PR; Einhorn TA; Genant HK; Geusens P; Klaushofer K; Lane JM; McKiernan F; McKinney R; Ng A; Nieves J; O'Keefe R; Papapoulos S; Howe TS; van der Meulen MC; Weinstein RS; Whyte MP
J Bone Miner Res; 2014 Jan; 29(1):1-23. PubMed ID: 23712442
[TBL] [Abstract][Full Text] [Related]
16. Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society.
van de Laarschot DM; McKenna MJ; Abrahamsen B; Langdahl B; Cohen-Solal M; Guañabens N; Eastell R; Ralston SH; Zillikens MC
J Clin Endocrinol Metab; 2020 May; 105(5):1682-99. PubMed ID: 31867670
[TBL] [Abstract][Full Text] [Related]
17. Outcomes between older adults with atypical and typical femoral fractures are comparable.
Khow KS; Paterson F; Shibu P; Yu SC; Chehade MJ; Visvanathan R
Injury; 2017 Feb; 48(2):394-398. PubMed ID: 27839798
[TBL] [Abstract][Full Text] [Related]
18. Atypical femoral fractures related to bisphosphonate treatment: issues and controversies related to their surgical management.
Koh A; Guerado E; Giannoudis PV
Bone Joint J; 2017 Mar; 99-B(3):295-302. PubMed ID: 28249967
[TBL] [Abstract][Full Text] [Related]
19. MANAGEMENT OF ENDOCRINE DISEASE: Atypical femoral fractures: risks and benefits of long-term treatment of osteoporosis with anti-resorptive therapy.
Adler RA
Eur J Endocrinol; 2018 Mar; 178(3):R81-R87. PubMed ID: 29339529
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate-associated femur fractures have high complication rates with operative fixation.
Prasarn ML; Ahn J; Helfet DL; Lane JM; Lorich DG
Clin Orthop Relat Res; 2012 Aug; 470(8):2295-301. PubMed ID: 22669553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
